Cardiorenal Syndrome clinical trials at UCSF

1 research study open to eligible people

Cardiorenal syndrome is when heart and kidney diseases worsen each other. UCSF is exploring the use of a device called Aortix for patients with serious heart problems. The study will compare this device to standard diuretic treatments.

Showing trials for

  • Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

    open to eligible people ages 21 years and up

    Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.

    San Francisco, California and other locations

Our lead scientists for Cardiorenal Syndrome research studies include .

Last updated: